• Gene therapy trials for sickle cell disease halted after two patients develop cancer

    10 days ago - By Gene Therapy

    Posted on: 22 February 2021,
    A company has stopped its clinical studies of a promising gene therapy for the blood disorder sickle cell disease after two people who participated developed leukemia-like cancer. Bluebird bio is now investigating whether a virus it uses to deliver a therapeutic gene caused the cancers, reviving old concerns about the risks of this approach. It's also possible the cancers stemmed from chemotherapy the patients received to prepare their bodies for the gene's delivery. “This is really a sad development whatever the cause,” says Donald Kohn of the University of...
    Read more ...